Qingdao, China

Huabo Chen


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huabo Chen: Innovator in Ophthalmic Microorganism Detection

Introduction

Huabo Chen is a distinguished inventor based in Qingdao, China. He has made significant contributions to the field of clinical microorganism detection, particularly in ophthalmology. His innovative work has led to the development of advanced diagnostic tools that enhance the accuracy and speed of microorganism detection in clinical samples.

Latest Patents

Huabo Chen holds a patent for "Probes, microarray, primers, kit and applications for rapid detection of clinical ophthalmic microorganisms." This patent discloses a range of probes and primers designed for the rapid detection of clinical microorganisms in ophthalmology. The probes are specifically tailored to detect various microorganisms, while the primers are capable of amplifying target bacteria with high intra-species homology and low inter-species homology. The invention also includes methods for synthesizing hybridization probes, conducting hybridization reactions, and scanning for detection. The probes are noted for their high specificity, allowing for accurate detection of microorganisms in ophthalmic clinical samples, delivering timely diagnoses.

Career Highlights

Huabo Chen is affiliated with the Affiliated Eye Institute of Shandong First Medical University, where he continues to advance research in ophthalmic diagnostics. His work has been pivotal in improving the methodologies used in clinical settings, ensuring that healthcare professionals can provide better patient care through rapid and accurate testing.

Collaborations

Huabo Chen has collaborated with notable colleagues, including Yusen Huang and Bining Zhang. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of ophthalmology.

Conclusion

Huabo Chen's contributions to the field of ophthalmic microorganism detection exemplify the impact of innovative research on clinical practices. His patented technologies are set to revolutionize the way microorganisms are detected in ophthalmology, ultimately improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…